J. López-González

发表

The novel immunomodulator IMMUNEPOTENT CRP combined with chemotherapy agent increased the rate of immunogenic cell death and prevented melanoma growth

M. Franco-Molina, E. Mendoza-Gamboa, R. Tamez-Guerra, 2017, Oncology letters.

Regulation Networks Driving Vasculogenic Mimicry in Solid Tumors

C. López-Camarillo, R. García-Vázquez, M. Muñiz-Lino, 2020, Frontiers in Oncology.

Lung squamous cell carcinoma and adenocarcinoma cell lines use different mediators to induce comparable phenotypic and functional changes in human monocyte-derived dendritic cells

G. Galindo-Rodríguez, C. Sánchez-Torres, S. Bajaña, 2006, Cancer Immunology, Immunotherapy.

Lung carcinomas do not induce T-cell apoptosis via the Fas/Fas ligand pathway but down-regulate CD3 epsilon expression

J. López-González, D. Aguilar-Cázares, H. Prado-Garcia, 2008, Cancer Immunology, Immunotherapy.

IL-6, NLR, and SII Markers and Their Relation with Alterations in CD8+ T-Lymphocyte Subpopulations in Patients Treated for Lung Adenocarcinoma

J. López-González, D. Aguilar-Cázares, M. Galicia-Velasco, 2020, Biology.

Evasion mechanisms to tumor necrosis factor α (TNF-α) of small cell lung carcinoma and non-small cell lung carcinoma cell lines : comparison with the erythroleukaemia K-562 cell line

A. Garcı́a, J. Mandoki, J. Caloca, 2000 .

Effector, memory and naïve CD8+ T cells in peripheral blood and pleural effusion from lung adenocarcinoma patients.

J. Mandoki, J. López-González, D. Aguilar-Cázares, 2005, Lung cancer.

Lung carcinomas decrease the number of monocytes/macrophages (CD14+ cells) that produce TNF-alpha.

J. Mandoki, J. López-González, D. Aguilar-Cázares, 2007, Clinical immunology.

The systemic-level repercussions of cancer-associated inflammation mediators produced in the tumor microenvironment

Á. Camarena, J. López-González, D. Aguilar-Cázares, 2022, Frontiers in Endocrinology.

Transcriptional analysis of hnRNPA0, A1, A2, B1, and A3 in lung cancer cell lines in response to acidosis, hypoxia, and serum deprivation conditions

J. López-González, H. Prado-Garcia, S. Romero‐Garcia, 2014, Experimental lung research.

miR‑145‑5p is associated with pathological complete response to neoadjuvant chemotherapy and impairs cell proliferation by targeting TGFβR2 in breast cancer.

S. Rodriguez-Cuevas, E. Ruíz-García, C. Pérez-Plasencia, 2019, Oncology reports.

Apoptosis and cell cycle disturbances induced by coumarin and 7-hydroxycoumarin on human lung carcinoma cell lines.

J. Molina-Guarneros, J. Mandoki, J. López-González, 2004, Lung cancer.

Activated T cells, but not lung tumor cells, express fas ligand.

J. López-González, H. Prado-Garcia, S. Romero‐Garcia, 2014, The Annals of thoracic surgery.

Tumor cell metabolism

J. López-González, D. Aguilar-Cázares, H. Prado-Garcia, 2011, Cancer biology & therapy.

Partners in crime: The feedback loop between metabolic reprogramming and immune checkpoints in the tumor microenvironment

J. López-González, D. Aguilar-Cázares, M. Galicia-Velasco, 2023, Frontiers in Oncology.

miRNAs, from Evolutionary Junk to Possible Prognostic Markers and Therapeutic Targets in COVID-19

M. Castillejos-López, Á. Camarena, J. López-González, 2021, Viruses.

Decrease of cyclin D1 in the human lung adenocarcinoma cell line A-427 by 7-hydroxycoumarin.

M. Velasco-Velázquez, J. Molina-Guarneros, F. A. Jiménez-Orozco, 2001, Lung cancer.

Single-cell microinjection assay indicates that 7-hydroxycoumarin induces rapid activation of caspase-3 in A549 cancer cells

J. Molina-Guarneros, J. López-González, Maribel Soto-Nuñez, 2015, Experimental and therapeutic medicine.

Expansion of quiescent lung adenocarcinoma CD8+ T cells by MUC1-8-mer peptide-T2 cell-β2 microglobulin complexes

L. Montaño, R. Lascuraín, D. Silva-Adaya, 2015, Oncology reports.

The Double-Edge Sword of Autophagy in Cancer: From Tumor Suppression to Pro-tumor Activity

J. López-González, D. Aguilar-Cázares, M. Galicia-Velasco, 2020, Frontiers in Oncology.

Old and New Players of Inflammation and Their Relationship With Cancer Development

Á. Camarena, J. López-González, D. Aguilar-Cázares, 2021, Frontiers in Oncology.

Localization and Level of Expression of β-Catenin in Human Laryngeal Squamous Cell Carcinoma

M. E. Vázquez-Manríquez, J. López-González, D. Aguilar-Cázares, 2004, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

Tumor-Induced CD8+ T-Cell Dysfunction in Lung Cancer Patients

J. López-González, D. Aguilar-Cázares, H. Prado-Garcia, 2012, Clinical & developmental immunology.

Lack of correlation between growth inhibition by TGF-β and the percentage of cells expressing type II TGF-β receptor in human non-small cell lung carcinoma cell lines

J. Mandoki, R. M. Rivera, J. López-González, 2002 .

LAP TGF-Beta Subset of CD4+CD25+CD127− Treg Cells is Increased and Overexpresses LAP TGF-Beta in Lung Adenocarcinoma Patients

J. López-González, D. Aguilar-Cázares, H. Prado-Garcia, 2015, BioMed research international.

Activation-induced cell death of memory CD8+ T cells from pleural effusion of lung cancer patients is mediated by the type II Fas-induced apoptotic pathway

J. López-González, D. Aguilar-Cázares, H. Prado-Garcia, 2012, Cancer Immunology, Immunotherapy.

Contribution of Angiogenesis to Inflammation and Cancer

C. López-Camarillo, J. López-González, D. Aguilar-Cázares, 2019, Front. Oncol..

[National consensus of diagnosis and treatment of non-small cell lung cancer].

R. Perez-Padilla, S. Allende-Pérez, A. Mohar-Betancourt, 2013, Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion.

Tumor-InducedCD8+T-CellDysfunctioninLungCancerPatients

J. López-González, D. Aguilar-Cázares, S. Romero‐Garcia, 2012 .

Dietary Compounds as Epigenetic Modulating Agents in Cancer

E. Ruíz-García, C. López-Camarillo, L. Marchat, 2019, Front. Genet..

Relationship of Dendritic Cell Density, HMGB1 Expression, and Tumor-infiltrating Lymphocytes in Non–Small Cell Lung Carcinomas

V. Rojo-León, R. Rivera-Rosales, J. López-González, 2014, Applied immunohistochemistry & molecular morphology : AIMM.

Abstracts from the 4th ImmunoTherapy of Cancer Conference

R. Rees, F. Regnier, A. Trautmann, 2017, Journal of Immunotherapy for Cancer.

Role of HMGB1 in Cisplatin-Persistent Lung Adenocarcinoma Cell Lines

S. Ávila-Ríos, J. López-González, D. Aguilar-Cázares, 2021, Frontiers in Oncology.

Cooperative multi-targeting of signaling networks by angiomiR-204 inhibits vasculogenic mimicry in breast cancer cells.

C. Pérez-Plasencia, C. López-Camarillo, M. E. Alvarez-Sánchez, 2018, Cancer letters.

Predominance of Th17 over regulatory T-cells in pleural effusions of patients with lung cancer implicates a proinflammatory profile.

J. López-González, H. Prado-Garcia, U. Rumbo-Nava, 2015, Anticancer research.

[Cytotoxic T lymphocytes in cancer and autoimmunity].

J. López-González, H. Prado-Garcia, F. Ávila-Moreno, 2004, Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion.

Transcriptional signature of early cisplatin drug-tolerant persister cells in lung adenocarcinoma

S. Ávila-Ríos, A. Méndez-Tenorio, J. López-González, 2023, Frontiers in oncology.